García-Correa ML, Chávez-Valencia V, Aguilar-Bixano O, Orizaga-de CC, Rojas-Hernández G, Gómez-de CL

Language: Spanish
References: 20
Page: 7-11
PDF size: 253.73 Kb.

ABSTRACT

Introduction: The renal consequences of kidney donation from a living donor are controversial. The general evidence regarding the risk living kidney donors (LKD) have regarding survival, end-stage kidney disease, cardiovascular and metabolic risks. Objective: To know the frequency of immediate cardiovascular and metabolic complications in related LKD post nephrectomy. Material and methods: Retrospective, cross-sectional, descriptive and analytical study of living kidney donors clinical and demographic variables were recorded, glomerular filtration rate (GFR) was calculated, prevalence of hypertension, diabetes mellitus, obesity and dyslipidemia were assessed. Results: 62 files of related living kidney transplantation between 2006-2019, were reviewed. Donor nephrectomies were left sided in 91.9% of cases. The post-donation evolution time was 53.9 ± 33 months, with an average follow-up to 1 year after renal donation. 54.8% are men, with an average age of 35.6 ± 10 years at the time of donation. 22.5% developed cardiovascular and/or metabolic complications, which were: dyslipidemia, mainly hypertriglyceridemia, followed by hypercholesterolemia. It should be noted that no donor has hypertension or diabetes, although 14% had glucose intolerance. The calculated GFR categorized 88.1% of post-renal donation patients within stage 2 of chronic kidney disease. No patient required post-kidney donation dialysis. Only the pre-donation GFR (p = 0.028) was associated with a GFR less than 60mL/min at 12 months. Conclusions: In short-term the frequency of cardiovascular and metabolic complications LKD such as hypertension, diabetes and proteinuria were zero. Nonpatient developed end-stage kidney disease. So, we may consider kidney donation to be safe in a short term.

REFERENCES

1. Arroyo C, Gabilondo F, Gabilondo B. El estudio del donador vivo para trasplante renal. Rev Invest Clín. 2005; 57 (2): 195-205.

2. Poggio ED, Braun WE, Davis C. The science of Stewardship: due diligence for kidney donors and kidney function in living kidney donation-evaluation, determinants, and implications for outcomes. Clin J Am Soc Nephrol. 2009; 4 (10): 1677-1684.

3. Gil-Terrón N, Cerain-Herrero MJ, Subirana I et al. Cardiovascular Risk in Mild to Moderately Decreased Glomerular Filtration Rate, Diabetes and Coronary Heart Disease in a Southern European Region. Rev Esp Cardiol (Engl Ed). 2020; 73 (3): 212-218. doi: 10.1016/j.rec.2018.12.006.

4. Price AM, Edwards NC, Hayer MK et al. Chronic kidney disease as a cardiovascular risk factor: lessons from kidney donors. J Am Soc Hypertens. 2018; 12 (7): 497-505. Available in: https://doi.org/10.1016/j.jash.2018.04.010

5. García G, Parramon D, Comas-Cufi M et al. Role of renal function in cardiovascular risk assessment: A retrospective cohort study in a population with low incidence of coronary heart disease. Preventive Medicine. 2016; 89: 200-206.

6. Yilmaz BA, Caliskan Y, Yilmaz A et al. Cardiovascular-renal changes after kidney donation: One-year follow-up study. Transplantation. 2015; 99 (4): 760-764.

7. Prasad GV, Lipszyc D, Huang M et al. A prospective observational study of changes in renal function and cardiovascular risk following living kidney donation. Transplantation. 2008; 86 (9): 1315-1318.

8. Garg AX, Meirambayeva A, Huang A et al. Cardiovascular disease in kidney donors: matched cohort study. BMJ. 2012; 344: e1203. doi: 10.1136/bmj.e1203.

9. Ibrahim HN, Foley R, Tan L et al. Long-term consequences of kidney donation. N Engl J Med. 2009; 360 (5): 459-469. doi: 10.1056/NEJMoa0804883.

10. Gai M, Giunti S, Lanfranco G et al. Potential risks of living kidney donation-a review. Nephrol Dial Transplant. 2007; 22 (11): 3122-3127.

11. Yazawa M, Kido R, Shibagaki Y et al. Kidney function, albuminuria and cardiovascular risk factors in post-operative living kidney donors: A single-center, cross-sectional study. Clin Exp Nephrol. 2011; 15 (4): 514-521.

12. Bello RC, Bello VA, Rosa TT et al. Male Gender and Body Mass Index Are Associated with Hypertension and Reduced Kidney Function 5 or More Years after Living Kidney Donation. Transplant Proc. 2015; 47 (10): 2816-2821. Available in: http://dx.doi.org/10.1016/j.transproceed.2015.10.041

13. Moody WE, Ferro CJ, Edwards NC et al. Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors. Hypertension. 2016; 67 (2): 368-377.

14. Karatas M, Tatar E, Kilic M et al. Surgical Stress Hyperglycemia Associated With New-Onset Diabetes in Living Kidney Donors. Transplant Proc. 2019; 51 (7): 2228-2231. Available in: https://doi.org/10.1016/j.transproceed.2019.01.18914.

15. Hernández D, Álvarez A, Armas A et al. Síndrome metabólico y donación renal de vivo: ¿contraindica la donación este síndrome Nefrologia. 2009; 29 (1): 20-29. doi: 10.3265/Nefrologia.2009.29.1.20.1.en.full.pdf.

16. Yadav R, Bhowmik D, Subbiah A et al. To study the impact of donor nephrectomy on blood pressure as measured by ambulatory blood pressure monitoring and renal function. Indian J Nephrol. 2019; 29 (4): 272-277.

17. Wainright JL, Robinson AM, Wilk AR et al. Risk of ESRD in prior living kidney donors. Am J Transplant. 2018; 18 (5): 1129-1139.

18. Rizvi SA, Zafar MN, Jawad F et al. Long-term Safety of Living Kidney Donation in an Emerging Economy. Transplantation. 2016; 100 (6): 1284-1293. doi: 10.1097/TP.0000000000001075.

19. Tsai S-F, Shu K-H, Wu M-J et al. A higher glomerular filtration rate predicts low risk of developing chronic kidney disease in living kidney donors. World J. Surg. 2013; 37 (4): 923-929.

20. Lim J, Kong YG, Kim YK et al. Risk Factors Associated with Decreased Renal Function after Hand-Assisted Laparoscopic Donor Nephrectomy: A Multivariate Analysis of a Single Surgeon Experience. Int J Med Sci. 2017; 14 (2): 159-166. doi: 10.7150/ijms.17585.